1. Gilenya, a disease-modifying therapy, may now be used to treat children 10 and up with multiple sclerosis.
2. Lucemyra is the first nonopioid treatment for adults managing opioid withdrawal symptoms.
3. Retacrit is a biosimilar version of the anemia therapy Epogen/Procrit.
4. BacterioScan 216DX transmits a laser through urine samples to detect bacteria associated with urinary tract infections.
5. Lokelma is intended to treat patients with hyperkalemia, a condition involving elevated potassium levels in the blood.
6. Doptelet is used to treat thrombocytopenia — a condition involving a low blood platelet count — in chronic liver disease patients set to undergo a medical or dental procedure.
More articles on supply chain:
How Mass General is dealing with the worst opioid shortage in years: 7 things to know
90% of ER physicians had shortages of critical medicine in the last month: 5 notes
Supply chain salaries jumped 4% in 2017: 5 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.